NATURE BIOTECHNOLOGY
Scope & Guideline
Transforming Ideas into Impactful Solutions
Introduction
Aims and Scopes
- Genome Editing and Engineering:
A central theme in the journal is the exploration and advancement of genome editing technologies, particularly CRISPR and its derivatives. This includes the development of novel editing systems that enhance specificity and reduce off-target effects. - Synthetic Biology:
Nature Biotechnology publishes studies on synthetic biology, which involves designing and constructing new biological parts, devices, and systems. This encompasses the engineering of microbes for applications in medicine, agriculture, and environmental sustainability. - Biotherapeutics and Drug Development:
The journal frequently features research on the development of biotherapeutics, including monoclonal antibodies, CAR-T therapies, and RNA-based therapeutics. This area focuses on the translation of basic research into clinical applications. - Bioinformatics and Computational Biology:
Computational approaches to analyzing biological data are a major focus, with studies leveraging machine learning, deep learning, and other computational tools to interpret complex biological datasets. - Microbiome Research:
Research on the microbiome and its implications for health and disease is increasingly prominent, reflecting a growing interest in understanding host-microbe interactions and their therapeutic potential. - Regenerative Medicine and Stem Cell Technology:
The journal covers advancements in regenerative medicine, including the use of stem cells for tissue engineering and the development of new therapies for degenerative diseases.
Trending and Emerging
- Advanced Genome Editing Techniques:
Newly developed genome editing tools, such as prime editing and base editing, are gaining traction. These methods promise greater precision and fewer off-target effects, driving interest in their applications across various fields. - Integration of AI in Biotechnology:
The application of artificial intelligence and machine learning in biotechnology is rapidly expanding. Researchers are leveraging these technologies for predictive modeling, data analysis, and optimizing biotechnological processes. - Personalized Medicine:
Research focused on personalized medicine, particularly in the context of cancer and rare diseases, is on the rise. This trend is driven by advancements in genomics and an increasing emphasis on tailored therapeutic approaches. - Sustainability and Environmental Biotechnology:
There is an emerging focus on biotechnological solutions aimed at addressing environmental challenges, such as bioremediation and sustainable agricultural practices, reflecting a broader societal push towards sustainability. - Cell and Gene Therapies:
The field of cell and gene therapies is rapidly advancing, with increasing numbers of studies exploring novel therapies and delivery methods, particularly in the context of genetic disorders and cancer treatment.
Declining or Waning
- Traditional Drug Discovery Methods:
As biotechnology evolves, traditional methods of drug discovery, which rely heavily on high-throughput screening of small molecules, are becoming less prominent. The focus has shifted towards more innovative approaches, such as utilizing AI and machine learning for drug development. - Plant Biotechnology:
Although still relevant, the frequency of publications specifically focused on plant biotechnology has decreased as the field expands into more integrated approaches combining multiple disciplines such as synthetic biology and gene editing. - Animal Models in Drug Testing:
There appears to be a decline in studies centered around traditional animal models for drug testing, as researchers increasingly explore alternative methods, including organoids and in vitro systems that better mimic human physiology. - Single-Cell Genomics:
While single-cell genomics remains important, there is a noticeable shift towards more integrative approaches that combine single-cell data with spatial transcriptomics and proteomics, indicating a transition away from isolated single-cell studies.
Similar Journals
CYTOTECHNOLOGY
Elevating Science: Bridging Concepts and Applications in Cytotechnology.CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.
MOLECULAR BIOTECHNOLOGY
Fostering Innovation at the Intersection of Science and TechnologyMOLECULAR BIOTECHNOLOGY, published by SPRINGERNATURE, is a pivotal journal in the fields of applied microbiology, molecular biology, biochemistry, and biotechnology. Since its inception in 1994, the journal has aimed to disseminate high-quality research that explores the intersection of molecular biology and technology, fostering advancements in biotechnology applications. With an ISSN of 1073-6085 and an E-ISSN of 1559-0305, it has established itself as a significant contributor to the scientific community, currently holding a Q3 ranking across multiple categories including Applied Microbiology & Biotechnology and Biochemistry in the 2023 metrics. Although not an open access publication, the journal remains accessible through various institutional subscriptions, providing valuable insights and findings to researchers and professionals. Given its ongoing commitment to quality and relevance, MOLECULAR BIOTECHNOLOGY serves as an essential resource for those involved in cutting-edge research and innovation in molecular biotechnology and related disciplines.
Biotechnology and Genetic Engineering Reviews
Pioneering Insights in the Evolving World of Biotech.Biotechnology and Genetic Engineering Reviews is a prominent journal published by Taylor & Francis Ltd, specializing in the rapidly evolving fields of biotechnology and genetic engineering. Since its inception in 1984, this journal has served as a critical platform for researchers and professionals to disseminate groundbreaking scientific findings, review methodologies, and discuss emerging trends within the domain. With a substantial track record of convergence in its publication history from various years, it currently holds Q2 rankings in both Bioengineering and Biotechnology, alongside a Q3 ranking in Molecular Biology for 2023. Its dedication to quality research is reflected in its Scopus rankings, which position the journal favorably within the competitive landscape of biochemistry and molecular biology. Although it is not an open-access journal, Biotechnology and Genetic Engineering Reviews remains committed to providing accessible insights to the global scientific community, making it an invaluable resource for students, academics, and industry professionals keen on advancing their knowledge in these crucial fields.
Journal of Zhejiang University-SCIENCE B
Unveiling the Latest Breakthroughs in Veterinary and Pharmacological SciencesThe Journal of Zhejiang University-SCIENCE B, published by ZHEJIANG UNIV PRESS, serves as a crucial platform for disseminating groundbreaking research across various fields including Biochemistry, Genetics, Molecular Biology, Medicine, Pharmacology, Toxicology, and Veterinary Science. With an impressive track record since its establishment in 2005, this journal continues to make significant contributions to scientific literature, ranking in the Q1 and Q2 quartiles as of 2023. This indicates its high relevance and impact within its respective fields, evidenced by its outstanding Scopus rankings, including a remarkable 4th position in Veterinary General and Pharmacology, indicating its authoritative voice in the scientific community. Researchers, professionals, and students are encouraged to explore this journal for insights and developments in innovative research, making it an essential resource for those dedicated to advancing the frontiers of science. The journal is accessible through traditional subscription models, ensuring that it remains a reliable source of high-quality research from China and beyond.
GEN Biotechnology
Connecting Fundamental Research to Real-World ImpactGEN Biotechnology, published by MARY ANN LIEBERT, INC, is a pivotal journal dedicated to advancing the field of biotechnology through the dissemination of high-quality research. With its ISSN 2768-1572 and E-ISSN 2768-1556, this journal seeks to bridge the gap between fundamental biotechnology research and its practical applications across various industries. As a leading publication in the life sciences arena, it emphasizes innovative studies in areas such as genetic engineering, molecular biology, bioinformatics, and synthetic biology. Although currently not open access, GEN Biotechnology offers a platform for researchers, professionals, and students to delve into cutting-edge findings that significantly impact health, agriculture, and environmental sustainability. Its commitment to excellence is underscored by its strive for high visibility within the global research community.
BIOTECHNOLOGY ADVANCES
Innovating Solutions for a Sustainable FutureBIOTECHNOLOGY ADVANCES is a premier, peer-reviewed journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to advancing knowledge in the rapidly evolving fields of biotechnology and bioengineering. With an ISSN of 0734-9750 and an E-ISSN of 1873-1899, this esteemed journal covers a wide spectrum of topics relevant to applied microbiology, molecular biology, and biochemical innovation. Recognized for its academic rigor, it holds a distinguished position in the top quartile (Q1) in multiple categories, including Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology, further evidenced by its high rankings in Scopus, where it ranks #3/127 in Applied Microbiology and Biotechnology and #7/311 in Biotechnology. Researchers and professionals in the field value the journal not only for its comprehensive coverage of cutting-edge research but also for its commitment to disseminating critical findings and fostering collaboration. While BIOTECHNOLOGY ADVANCES currently operates under a subscription model, its potential impact on future innovations in biotechnology cannot be overstated, making it an essential resource for anyone interested in the forefront of biotechnological advancements.
BIOCELL
Elevating Scientific Dialogue in Cell BiologyBIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.
Bioengineered
Revolutionizing Access to Cutting-edge BiotechnologyBioengineered, published by TAYLOR & FRANCIS INC, is an esteemed Open Access journal that has been at the forefront of research in the fields of bioengineering, biotechnology, and applied microbiology since its inception in 2012. With an impressive impact factor reflecting its high-quality contributions, the journal is categorized in the top quartiles, achieving Q1 rankings in Applied Microbiology and Biotechnology, as well as in Biotechnology and Medicine (Miscellaneous) for 2023. This active engagement in showcasing pioneering research is critical for professionals and students alike, facilitating access to revolutionary studies and methodologies. The journal operates under an Open Access model since 2018, ensuring that groundbreaking findings in bioengineering are readily accessible to a global audience. Situated in the United Kingdom, Bioengineered not only serves as a platform for innovative research but also underscores the importance of interdisciplinary collaborations among scientists, engineers, and biotechnologists.
PROTEIN EXPRESSION AND PURIFICATION
Pioneering Insights in Biochemistry and Molecular BiologyPROTEIN EXPRESSION AND PURIFICATION, published by Academic Press Inc. Elsevier Science, is a premier journal in the field of biotechnology. With its ISSN 1046-5928 and E-ISSN 1096-0279, the journal has been a vital source of knowledge since its inception in 1990 and continues to provide high-quality research up to 2025. Though categorized in the third quartile (Q3) for 2023 within its scope of biochemistry, genetics, and molecular biology, it serves as a valuable platform for scientists and researchers focusing on the latest advancements in protein expression methodologies and purification techniques. The journal enjoys a respectable Scopus rank of 177 out of 311 in its category, representing a 43rd percentile position that underscores its impact in the research community. While not an Open Access journal, it offers a wealth of insights that can significantly enhance one's understanding of protein biochemistry, making it a must-read for professionals and students alike engaged in this dynamic field.
JOURNAL OF BIOTECHNOLOGY
Advancing biotechnological frontiers since 1984.JOURNAL OF BIOTECHNOLOGY, published by Elsevier, stands as a premier platform in the fields of Applied Microbiology, Biotechnology, Bioengineering, and Medicine. With an ISSN of 0168-1656 and an E-ISSN of 1873-4863, this journal has significantly contributed to the advancement of biotechnological research since its inception in 1984 and continues to be a vital resource until 2024. Notably ranked in the Q2 quartile across multiple categories, it excels with impressive Scopus rankings, placing within the top 20% in Applied Microbiology and Biotechnology. This underscores its impact on both the scientific community and the ongoing developments in biotechnological applications. The journal encourages submissions that promote innovative research and practical insights, fostering collaboration among researchers, professionals, and students alike. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and commitment to excellence in biotechnological literature.